40
ߤ
Ϊɿίе
ޥ
ˀᏐʕϞ䋠ࠠ
ࠅ
ٙจ່f
淋巴水腫
νɪ
ࠑה
dˋ၍Ϟ૰ࣙ༸ʘ၈dΪϤd̴ί
ଡ଼ᔌ૰͍ٙ੬ၪܵɪdϞᑘԑჀࠠٙЪ͜fί͍੬
ઋ
ر
ɨdଡ଼ᔌ૰ʔᓙ͛ϓdɦʔᓙΫသdϾԴА
ᆉeଡ଼ᔌග૰ձˋ૰ɧ٫ʘග
ڭ
̻ܵፅfνଡ଼ᔌ
૰͛ϓཀεd
א
Ϋသღᖟd
ک
ึԴଡ଼ᔌගქ૰⽌
वdҖϓ˥໕fνΪˋΫ
ݴ
ա
ڜ
ˏৎٙ˥໕d၈
މ
ˋ˥໕fˋΫ
ݴ
ա
ڜ
ٙࡡΪd̙˸͟ˋ
၍˂೯ԃʔԄeˋ၍ᖙᇫ̌ঐʔΌ
א
ॹνഃf
һ੬Ԉٙ݊ᘱ೯കᔥष
א
ᗡଢഽช
ݑ
ˏৎٙˋ
၍ٙ
ڜ
෦fԪᐖ࣬
ط
ஔ
ܝ
d੬ึΪണɨˋଡ଼ᔌٙ
ॎᕸd
ߧ
ԴˋΫ
ݴ
ღᖟd̈ତɪ
ٮ
ˋ˥໕f
ˋ˥໕ࣛd͟ጐၳٙˋ૰బўஐͣሯd
ڗ
ಂՐ
ዧԴഐᇕଡ଼ᔌମ੬ᄣ͛dͤᇮᄣ
ێ
dҖϓ
ה
ፗͤ
໕f
淋巴結(頸部)轉移癌
᎕ˋഐ໕ɽd੬੬ึˏৎɛ
ࡁ
ٙᙆઑd݊ʔ݊
ᔷᐖkˋഐ໕ɽdՉྼৰᐖस̮dᒔ̙˸ϞՉ
̴ࡡΪdՉʕ௰੬Ԉٙ݊
ف
सfν
؈
݊
ف
सdɓছ
ϞᏀ೨eٜࢰɽʃɓছʔ൴ཀ
2
ʮʱd
ف
सऊ̰
ΝࣛᒔึΣɪᇶַdவఱ݊ˋ၍
ف
dϾ˲໖ٰ๖
ٙˋഐɰึ໕ɽৎԸdவ݊Ϊ
މ
ഽˋഐவ
ࡈ
ᗫ̔
ڜ
ཞٙᇝ݂dϾѳ˟əഽ
א
Ϟ
ي
ሯආ
ɝА૰ృᐑfɦνdɰ੬ᛓႭᐖ
ߤ
ٙˋ༸ᔷ
dவ݊ɓ
ࡈ
ઃᐖसࣛɓ
ࡈ
ʔλٙৃࢹdႭᐖस
ʊ߉ॎəࡡԸٙ҅ࠢdஷཀˋ༸ΣჃஈኜ֜ᔷ
dவఱᄣ̋ə࿁ᐖसٙ
ط
ᐕٙᗭ
ܓ
fˋഐί
lzٙʱ̺Ϟɓ֛ٙ
ܛ
dϗॶٙˋɰϞɓ֛ٙᇍ
ఖfԷνd؆ˋഐeЀ
ܝ
ˋഐeɨቬˋഐ
ഃd˴
ࠅ
ϗॶԸІ᎘᎕ٙˋfᄀۚᐖ੬Ԉֻ᎕
ܝ
ɧԉਜˋഐᔷiᕁ৶ɨˋഐeണˋഐ˴
ࠅ
ϗॶɪ
ٮ
ٙˋfԪᐖ੬ֻണˋഐᔷi⧑
ˋഐe໖ٰ๖ˋഐ˴
ࠅ
ϗॶɨ
ٮ
e̮ഃஈٙ
ˋfΪϤdˋഐٙ໕ɽd࿁кᓙช
໕אݑ
ᆯٙ
Ը๕Ϟ
ה
Ꮝпf
淋巴細胞是免疫系統的「主角」
ɛٙе
ޥ
ߤ
˴
ࠅ
͟ˋ
ߤ
ଡ଼ϓf˴
ࠅ
Ϟ
T
ˋ
ߤ
(
ᔊ၈
T
ߤ
)
ձ
B
ˋ
ߤ
(
ᔊ၈
B
ߤ
)
Շɽᗳf
T
ߤ
ঐ૨ෆe๓༆ମ
ߤ
eʱ
ؤ
ˋΪɿeਞ
ၾ
ߤ
е
ޥ
i
B
ˋ
௰ߤ
ʱʷϓᆉ
ߤ
dঐʱ
ؤ
၇Ҥdਞၾ૰е
ޥ
f
T
ߤ
ձ
B
ߤ
ίе
ޥ
ˀᏐʕΝЪdጏlzᅮձ̮ᅮf̴̙˸ᢖ
ጏष
ݭ
eഽeॆഽձ͛ᔥഃ၇षࡡٙ
ڧ
ᛕd
ᒔ̙˸ʕձ
९ݭ
fɓ͇வ၇̌ঐʔԑࣛdึኬ
ߧ
е
ޥ
ॹषᘣfШˀᏐཀ৷ࣛd
ۆ
ึˏৎཀઽˀᏐd
νᖹ
ي
ཀઽe
ي
ཀઽeࡲఁeⱉ௦ऽഃf̴ᒔঐ
ৰฦෆ
א
সϼٙ
ߤ
dШ߰Ϥ̌ঐ̰ሜࣛdˀึ
ˏৎІԒе
ޥ
षfе
ޥ
ӻ୕ɰϞԣ˟ᐖᜊٙ̌ঐf
淋巴因子是免疫反應的「信使」
ཀ̘ኪ٫ಀ೯ତ
T
ߤ
ঐʱ
ؤ
ɓԬΪɿd၈
މ
ˋΪ
ɿf
90
ϋ˾
ܝ
dˋΪɿձՉ̴
ߤ
ʱ
ؤ
ٙΪɿ୕
ɓնΤ
މ
ߤ
Ϊɿ
(ytokine
d
CK)
f
ߤ
Ϊɿ݊ɓɽ
ᗳ
ڦ
Դஐͣdί
ߤ
ගৎ
ڦ
ࢹෂʧሯٙЪ͜f࿁
ߤ
ٙεධ̌ঐϞሜືٙ̌ঐfอ
ڐ
Ӻd࣬ኽʱ
ؤ
ߤ
ΪɿٙʔΝ
CD-4-T
ߤ
̙ʱ
މ
T helper-1(TH1)
ߤ
ձ
T helper-2(TH2)
ߤ
Շ၇ԭۨf
TH1
ߤ
˴
ࠅ
ʱ
ؤ
ٙ
ߤ
Ϊɿ݊
IL-2
ʿ
INF-r
f̴ٙ˴
ࠅ
̌ঐ݊ˏ
ৎַ፰ཀઽˀᏐe
ݭߤ
ձ
ߤ
е
ޥ
ˀᏐf
Ͼ
TH2
ߤ
˴
ࠅ
݊ʱ
ؤ
IL-4
ʿ
IL-5
f̴˴
ࠅ
ٙЪΪ݊
пପ͛Ҥe
IgE
ʿ૰е૰ˀᏐf͟Ϥ̙Ԉd
µ
ˋӻ୕ᅼόྡ
預防勝於治療